SCHEMBL29530692

SCHEMBL29530692

Cn1cc(S(=O)(=O)C(F)(F)C2CCN(C(=O)Nc3ccnnc3)CC2)c(C(F)F)n1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 1/20 0.35
TRPV1 Q8NER1 5/20 0.34
NAMPT P43490 2/20 0.34
LMNA P02545 2/20 0.33
NPSR1 Q6W5P4 1/20 0.33
NTRK1 P04629 1/20 0.33
KCNH2 Q12809 1/20 0.33
NTRK3 Q16288 1/20 0.33
NTRK2 Q16620 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA2B P29275 1/20 0.33
ADORA1 P30542 1/20 0.33
RORC P51449 1/20 0.33
CNR2 P34972 1/20 0.33
IRAK4 Q9NWZ3 1/20 0.32
TSHR P16473 2/20 0.32
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17948892 1.00 EPHX2 (0.35) EPHX2TRPV1NAMPTLMNANPSR1
SCHEMBL17949350 0.93 EPHX2 (0.35) EPHX2TRPV1NAMPTLMNANPSR1
SCHEMBL29530086 0.93 EPHX2 (0.35) EPHX2TRPV1NAMPTLMNANPSR1
SCHEMBL17949470 0.92 LMNA (0.35) EPHX2TRPV1NAMPTLMNANPSR1
SCHEMBL29529674 0.92 LMNA (0.35) EPHX2TRPV1NAMPTLMNANPSR1
SCHEMBL29529681 0.87 EPHX2 (0.37) EPHX2TRPV1NAMPTLMNANPSR1
SCHEMBL29529739 0.87 TRPV1 (0.38) EPHX2TRPV1LMNANPSR1NTRK1
SCHEMBL17948895 0.87 EPHX2 (0.37) EPHX2TRPV1NAMPTLMNANPSR1
SCHEMBL17948891 0.87 TRPV1 (0.38) EPHX2TRPV1LMNANPSR1NTRK1
SCHEMBL17949060 0.86 LMNA (0.36) EPHX2TRPV1LMNANPSR1NTRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250275952-A1 4-METHYLSULFONYL-SUBSTITUTED PIPERIDINE UREA COMPOUNDS MYOKARDIA INC (US) 2025-09-04 US disclosed
US-20220117955-A1 4-METHYLSULFONYL-SUBSTITUTED PIPERIDINE UREA COMPOUNDS MyoKardia, Inc. 2022-04-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250275952-A1 4-METHYLSULFONYL-SUBSTITUTED PIPERIDINE UREA COMPOUNDS TNNI3, UMPS, TNNT2 EPHX2 4273/4885TRPV1 2569/4885NAMPT 3617/4885
US-20220117955-A1 4-METHYLSULFONYL-SUBSTITUTED PIPERIDINE UREA COMPOUNDS TNNI3, UMPS, TNNT2 EPHX2 4273/4885TRPV1 2569/4885NAMPT 3617/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.